Citation Impact
Citing Papers
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
The influence of age on the activity of acetylsalicylic acid-esterase and protein-salicylate binding
1974
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Prevention of perioperative deep vein thrombosis in general surgery: A multicentre double blind study comparing two doses of Logiparin and standard heparin
1991
Proficient and Cost-Effective Approaches for the Prevention and Treatment of Venous Thrombosis and Thromboembolism
2000
A randomised controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery
1993
Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Elderly Patients
2007
Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery
2007
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
1999
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin‐induced Thrombocytopenia
2007
Prognosis and Management after a First Myocardial Infarction
1990
Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen
1992
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer
2006
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Efficacy and Safety of Weight-Adapted Nadroparin Calcium vs. Heparin Sodium in Prevention of Clinically Evident Thromboembolic Complications in 1,190 General Surgical Patients
2000
Nadroparin in the Prevention of Deep Vein Thrombosis in Acute Decompensated COPD
2000
Prevention of fatal pulmonary embolism and mortality in surgical patients
2005
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
1996 Standout
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique
1991
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Platelet Activation and Atherothrombosis
2007 Standout
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
1993
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Diabetes and Atherosclerosis
2002 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Argatroban therapy in heparin-induced thrombocytopenia
2008
Prevention of Venous Thromboembolism
2004 Standout
Warfarin, Aspirin, or Both after Myocardial Infarction
2002
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Prophylactic aspirin and risk of peptic ulcer bleeding
1995
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation
1993
A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
1995
Prophylaxis of Venous Thromboembolism Using Two Different Doses of Low-Molecular-Weight Heparin (Nadroparin) in Bariatric Surgery: A Prospective Randomized Trial
2001
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Diclofenac Sodium
1988
Argatroban
2009
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)
2013
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Hemorrhagic Complications of Anticoagulant Treatment
1998
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
1992
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
The Rate of Bleeding Complications After Pharmacologic Deep Venous Thrombosis Prophylaxis
2006
Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Thromboprophylaxis in Patients With Cancer<subtitle>A Systematic Review and Meta-analysis</subtitle>
2008
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Prevention of Venous Thromboembolism
1998
Hemorrhagic Complications of Anticoagulant Treatment
2004
A Systematic Review of Deep Venous Thrombosis Prophylaxis in Cancer Patients: Implications for Improving Quality
2006
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
1998
Low molecular weight heparin in prevention of perioperative thrombosis.
1992
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
1989
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
2003
Secondary Prevention for Ischemic Heart Disease
1997
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review
2020
Isolation of a chemical trigger for thrombosis
1974
Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery
2004
Potential therapeutic applications of aspirin and other cyclo‐oxygenase inhibitors.
1980
Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review
2015
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
Aspirin after myocardial infarction
1989
Prevention of Venous Thromboembolism
1992
Review papers : The statistical basis of meta-analysis
1993
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
1993
Aspirin and Other Platelet-Active Drugs
1992
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1989
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
1987
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus
1970
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Prophylaxis of postoperative thromboembolism with low molecular weight heparins
1993
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
2007
Hemorrhagic Complications of Anticoagulant Treatment
1992
Low Molecular Weight Heparin and Prevention of Postoperative Thrombosis in Abdominal Surgery
1992
Blood pressure, stroke, and coronary heart disease
1990 Standout
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1986
Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
1983
Prospective Trial of Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Moderately Injured Patients
1999
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
2014
Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura
1994
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
2001 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Low-Molecular-Weight Heparins
1997 Standout
Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement
1980
Hemorrhagic Complications of Anticoagulant Treatment
1995
Comparison of Unfractionated Versus Low Molecular Weight Heparin for Deep Vein Thrombosis Prophylaxis During Breast and Pelvic Cancer Surgery: Efficacy, Safety, and Follow-up
1998
Prostaglandins and Thromboxanes
1978 StandoutNobel
PLATELET ABNORMALITIES IN VON WILLEBRAND'S DISEASE*
1972
Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery
1996
Prevention of Venous Thromboembolism
1995
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2013
Peripheral Arterial Disease in Diabetic and Nondiabetic Patients
2001
Diabetes and cardiovascular disease. The Framingham study
1979 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Secondary prevention after myocardial infarction: A review of long-term trials
1982
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
The molecular immunology of human platelet proteins
1992
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Meta-analysis in clinical trials
1986 Standout
Vessel injury, platelet adherence, and platelet survival.
1983
Works of K Breddin being referenced
Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: First results from the ARG-E03 trial
2006
[Inhibition of platelet aggregation with acetylsalicylic acid. Experimental and clinical results].
1971
[ON THE INCREASED AGGLUTINATION OF THROMBOCYTES IN VASCULAR DISEASES].
1965
[Does Diclofenac modify oral anticoagulant therapy and platelet aggregation?].
1977
Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images
1981
Secondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon
1980
Prävention postoperativer thrombotischer Komplikationen mit Heparin und Dihydroergotamin: Eine randomisierte, kontrollierte Doppelblindstudie
2008
Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo
1979
Zur Messung der Thrombozytenadhäsivität
1964
German-Austrian Multicenter two Years Prospective study on the Prevention of Secondary Myocardial Infarction by ASA in Comparison of Phenprocoumon and Placebo
1977
Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery
1988
The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
1980
Acquired Disorder of Platelet Function Associated with Autoantibodies against Membrane Glycoprotein IIb-IIIa Complex - 1. Glycoprotein Analysis
1991
Thromboseprophylaxe mit Aspirin?
1969